Ana sayfa
Piyasalar
Grafikler ve fikirler
Algo
Haberler
Store
Aracı kurumlar
İndir
Ekonomik Takvim
Alım-satım sinyalleri
Web Terminali
Arama yapmak için
/
tuşuna basın: @kullanıcı, $sembol, ...
Ara
Giriş yap
Hesap oluştur
Türkçe
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
ADMA
#1300
ADMA Biologics, Inc.
15.5
7
+5.49%
Sektör:
Baz:
Kar para birimi:
Günlük aralık
Yıllık aralık
Günlük değişim
+5.49%
Aylık değişim
-5.98%
6 aylık değişim
-10.05%
Yıllık değişim
+1.43%
Önceki kapanış
14.7
6
Open
15.5
7
Bid
Ask
Low
15.5
7
High
15.5
7
Hacim
204
Piyasalar
ABD hisse senetleri
Sağlık hizmetleri
ADMA
Open full chart
Financials
Overview
Rapor
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
Q4, 25
TTM
Key stats
Total common shares outstanding
236.39 M
237.62 M
238.73 M
238.63 M
238 M
238.16 M
—
Valuation ratios
Enterprise value
4.64 B
3.97 B
4.66 B
4.26 B
3.43 B
4.26 B
16.6 B
Price to earnings ratio
71.39
21.17
23.62
21.42
17.25
30.4
92.69
Price to sales ratio
12.43
9.79
10.53
9.42
7.36
8.76
36.07
Price to cash flow ratio
70.94
35.17
35.48
57.67
54.73
88.64
236.52
Price to book ratio
6.71
11.96
4.23
3.3
2.32
9.36
19.22
Enterprise value to EBITDA ratio
37.87
27.08
29.2
26.04
19.6
21.34
96.18
Profitability ratios
Return on assets %
0.09
0.23
0.05
0.06
0.06
0.08
0.26
Return on equity %
0.15
0.32
0.07
0.09
0.08
0.1
0.35
Return on invested capital %
60.02
-46.71
30.67
36.94
36.43
42.84
146.87
Gross margin %
49.78
53.88
53.22
55.11
56.34
63.82
228.49
Operating margin %
33.08
32.6
30.38
35.08
38.01
45.09
148.57
EBITDA margin %
34.66
34.3
32.04
36.72
39.5
46.6
154.86
Net margin %
29.96
95.19
23.44
28.05
27.14
35.48
114.11
Liquidity ratios
Quick ratio
3.26
2.9
3.36
2.78
3.65
3.74
13.52
Current ratio
7.09
5.97
6.58
5.33
7.13
6.71
25.74
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
0.31
0.27
0.23
0.23
0.24
0.23
0.93
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
0.26
0.15
0.14
0.13
0.12
0.11
0.51
Long term debt to total equity ratio
0.44
0.21
0.19
0.18
0.16
0.15
0.69
Per share metrics
Operating cash flow per share
0.1
0.21
0.08
-0.07
0.05
0.15
0.21
EBIT per share
0.16
0.16
0.14
0.17
0.21
0.26
0.78
EBITDA per share
0.17
0.17
0.15
0.18
0.22
0.26
0.81
Total debt per share
—
—
—
—
—
—
—
Cash per share
0.35
0.42
0.29
0.36
0.25
0.36
1.26
Net current asset value per share
1.3
1.36
1.44
1.61
1.65
1.9
6.6
Tangible book value per share
0.93
1.42
1.51
1.59
1.75
1.93
6.77
Working capital per share
1.12
1.13
1.22
1.31
1.41
1.62
5.56
Book value per share
0.95
1.43
1.53
1.6
1.76
1.95
6.84
Haberler
Alkermes Down Despite Q4 Earnings Beat, Announces Leadership Change
ADMA Q4 EPS Up 14% Y/Y, Revenues Gain From Strong Asceniv Performance
Mirum's Q4 Earnings Lag, Higher Product Sales Drive Y/Y Revenues
ADMA Biologics Inc kazancı $0,03 ile beklentilere göre daha iyi, kâr ise beklentilere göre düşük
ADMA Biologics Inc earnings beat by $0.03, revenue fell short of estimates
ADMA Biologics kazanç açıklaması yaklaşıyor: Hedeflere ulaşabilecek mi?
Can OPKO Health's Pipeline Progress and Deals Drive Growth in 2026?
Adma Biologics Başkanı Adam Grossman, 337.679 dolar değerinde hisse satışı gerçekleştirdi
Adam Grossman, president of Adma Biologics, sells $337,679 in shares
Novocure Gains FDA Approval for Optune Pax to Treat Pancreatic Cancer
NeoGenomics Announces Launch of New Cancer Assay PanTracer Pro
Adma Biologics (ADMA) Registers a Bigger Fall Than the Market: Important Facts to Note